Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.

BMC Cancer · 2017 · PMC5575900 · PMID 28851310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

However, pre-diagnostic use of warfarin for 5 years or more was associated with a borderline significant risk increase in the multivariable-adjusted model (HR 1.49, 95% CI 0.97-2.28).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.